Skip to main content
OpenTrials
Completed

NCT Number: NCT04760158

Comparison of New Technique Taping and Placebo Taping on Patellofemoral Pain Syndrome: A Randomised Controlled Study

We included in this study 42 individuals with patellofemoral pain syndrome. 39 of them were completed six weeks of exercise and other groups. We randomized them into three groups. One group is the star technique which is a new patellar taping technique. Another group is placebo taping and the third group is only the exercise group. Both groups performed exercises three times a week for six weeks. Three groups were assessed with knee and hip muscles strength, shortness, performance tests, pain severity in the activity, night, rest, and knee-buckling, and Kujala Scale before and after 4-week exercises.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Kırıkkale University

Kirikkale, Yahşihan, 71140, Turkey (Türkiye)

About this study

Based on previous studies those participants who met the following inclusion criteria were invited to participate in the study: i) insidious onset of anterior knee pain with a duration greater than 4 weeks; ii) pain provoked by at least two of the following situations: prolonged sitting or kneeling, squatting, running, hopping or ascending or descending stairs; iii) age ranged between 18-60 years.

Participants were excluded in cases of the clinical history of patellofemoral dislocation or subluxation; knee osteoarthritis; injury or pain from the hip, lumbar spine, or other knee structures (meniscus, ligaments, bursa, synovial plica, infrapatellar fat); traumatic lesions of soft tissues or previous orthopedic surgery in lower limbs; having received knee injections of corticosteroids or hyaluronic acid; cognition or impaired communication; being involved in an ongoing medical-legal dispute; using Canadien or walker; can not walk independently and having an allergy to taping.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • insidious onset of anterior knee pain with a duration greater than 4 weeks;
  • self-reported patellofemoral pain intensity ≥30 mm on the 100 mm Visual Analogue Scale (VAS)
  • pain provoked by at least two of the following situations: prolonged sitting or kneeling, squatting, running, hopping, or ascending or descending stairs;
  • age ranged between 18-60 years.

Exclusion criteria

  • the clinical history of patellofemoral dislocation or subluxation; knee osteoarthritis; injury or pain from the hip, lumbar spine, or other knee structures (meniscus, ligaments, bursa, synovial plica, infrapatellar fat)

-); traumatic lesions of soft tissues or previous orthopedic surgery in lower limbs; having received knee injections of corticosteroids or hyaluronic acid

  • cognition or impaired communication
  • being involved in an ongoing medical-legal dispute
  • using Canadien or walker; can not walk independently
  • having an allergy to taping

Treatment and study plan

Exercise

Other

Participants of this study exercised strengthening and stretching 3 days a week for 6 weeks

Primary outcomes

  1. comparision of the effects of new patellar taping technique and placebo taping on performance

    Time frame: 6 weeks

    we analyzed and compared the performance test outcomes.

Sponsors and collaborators

Lead sponsor

Hacettepe University

Other

Registry information

Official study title

New Technique For Taping on Patellofemoral Pain Syndrome

Important dates

Study start
2019
Primary completion
2020
Study completion
2021
First posted
Feb 18, 2021
Registry last updated
Feb 18, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.